MedicinePOM

Sitagliptin + Metformin

A combination tablet of sitagliptin and metformin that lowers blood sugar in type 2 diabetes.

Clinical information

Common uses

type 2 diabetes, alongside diet and exercise

Common side effects

diarrhoea
upper respiratory tract infection
headache

Cautions

boxed warning: lactic acidosis risk, especially with kidney problems
pancreatitis can occur — stop if suspected
may lower vitamin B12 levels
not for type 1 diabetes

Interactions

carbonic anhydrase inhibitors, e.g. topiramate, acetazolamide
drugs that reduce metformin clearance, e.g. cimetidine, dolutegravir
alcohol — raises lactic acidosis risk
insulin or insulin secretagogues — low blood sugar risk

Pregnancy: only if prescribed — talk to your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Zituvimet (sitagliptin and metformin) label, setid 0098dec4-f0e5-45d5-8aa4-5d0faf9ab142 (accessed 2026-08-16)

Approved brands & formulations7

Brand name	Dosage form	Strength	Importer	Category
Glipita-M 50/500	Tablet ( Film coated )	50MG+ 500MG	authorized importers after registration of the product	POM
Sitagliptin Phosphate +Metformin Hcl	Tablet	50mg + 1000mg	—	POM
Sitagliptin Phosphate+Metformin Hcl	Tablet	50mg+500mg	—	POM
Sita - Met	Tablet ( Film coated )	50 mg+ 500 mg (BP)	State Trading Organization Plc	POM
Swizglipt M	Tablet ( Film coated )	50 mg (USP) + 500 mg (USP)	AMDC Pvt. Ltd	POM
Swizglipt M forte	Tablet ( Film coated )	50mg (USP) + 1000mg (USP)	AMDC Pvt. Ltd	POM
Taglimet 50/500	Tablet ( Film coated )	50MG+ 500MG	authorized importers after registration of the product	POM